Atos commits to net-zero carbon emissions by 2035, setting the highest decarbonization standards for its Industry

Paris, June 24, 2020

Atos, a international leader in electronic transformation, announces right now its dedication to realize internet-zero carbon emissions by 2035, a date which is 15 several years forward of the bold intention of the UN Paris Arrangement on Weather Adjust to restrict the international warming of the world to 1.5oC as opposed to pre-industrial stages (internet-zero by 2050). This conclusion expands Atos’ ambitions on decarbonization even further more, positioning decarbonization as a main ingredient of its expansion technique and the Corporation as the decarbonization leader in its Field.

This dedication will see Atos reduce

Read More

Import duty on bamboo for agarbatti industry hiked to 25%

In an effort and hard work to curb an additional import from China, India on Tuesday hiked import duty on bamboo for agarbatti (incense adhere) to twenty five for each cent.

“Customs duty on bamboo imports by agarbatti manufacturers hiked from ten for each cent to twenty five for each cent with instant result to stimulate use of domestic bamboo for AtmaNirbhar Bharat,” Central Board of Oblique Taxes and Custom (CBIC) reported in a tweet. CBIC is apex coverage making body for oblique taxes this kind of as Products & Solutions Tax (at Central stage) and Custom Duty.

The board

Read More

Atos and Siemens introduce Digital Twin solution within the global pharmaceutical industry

Paris, France Munich, Germany – May well eighteen, 2020

Atos, a worldwide chief in digital transformation and Siemens, a worldwide engineering chief, are doing the job with each other with the pharmaceutical  industry to improve production with an revolutionary alternative centered on a digital reproduction of the pharma production approach. Currently remaining examined in the pharmaceutical business, this revolutionary “Process Digital Twin” for pharma production – powered by IoT, AI and Superior Analytics – is designed to provide enhanced performance and adaptability in the production of pharmaceutical products.

Dependent on the pilot study, this possibly disruptive alternative

Read More

Academics and industry unite to imp… – Information Centre – Research & Innovation